Fidson Healthcare Plc (NGX:FIDSON)

Market Cap	50.49B
Revenue (ttm)	100.32B
Net Income (ttm)	7.99B
Shares Out	2.29B
EPS (ttm)	3.49
PE Ratio	6.31
Forward PE	n/a
Dividend	1.00 (4.55%)
Ex-Dividend Date	Jul 14, 2025

Volume	1,620,833
Average Volume	532,304
Open	21.00
Previous Close	20.45
Day's Range	21.00 - 21.00
52-Week Range	12.40 - 21.00
Beta	0.24
RSI	77.84
Earnings Date	Apr 28, 2025

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered i...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 674
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: FIDSON

Financial Performance

In 2024, Fidson Healthcare's revenue was 84.19 billion, an increase of 58.70% compared to the previous year's 53.05 billion. Earnings were 5.78 billion, an increase of 60.20%.